Filter News
Area of Research
- (-) Mathematics (1)
- (-) Nuclear Science and Technology (9)
- (-) Quantum information Science (2)
- Advanced Manufacturing (2)
- Biological Systems (2)
- Biology and Environment (86)
- Biology and Soft Matter (1)
- Clean Energy (60)
- Climate and Environmental Systems (2)
- Computational Engineering (1)
- Electricity and Smart Grid (1)
- Energy Frontier Research Centers (1)
- Functional Materials for Energy (1)
- Fusion and Fission (5)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (26)
- Materials (76)
- Materials for Computing (12)
- National Security (9)
- Neutron Science (21)
- Supercomputing (64)
News Type
News Topics
- (-) Bioenergy (2)
- (-) Climate Change (1)
- (-) Isotopes (5)
- (-) Microscopy (2)
- (-) Nanotechnology (1)
- (-) Space Exploration (5)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Biomedical (2)
- Clean Water (1)
- Computer Science (9)
- Coronavirus (1)
- Cybersecurity (3)
- Decarbonization (1)
- Environment (2)
- Fusion (8)
- Grid (1)
- Materials Science (3)
- Mathematics (1)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (3)
- Quantum Science (9)
- Sustainable Energy (2)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.